Cargando…

Classic psychedelics do not affect T cell and monocyte immune responses

INTRODUCTION: Classic psychedelics have been shown to exert therapeutic potential for the treatment of various psychiatric disorders, neuropsychiatric diseases, and neuronal damage. Besides their psychopharmacological activity, psychedelics have been reported to modulate immune functions. There has...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rudin, Deborah, Areesanan, Alexander, Liechti, Matthias E., Gründemann, Carsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895091/ https://www.ncbi.nlm.nih.gov/pubmed/36741125 http://dx.doi.org/10.3389/fpsyt.2023.1042440

Ejemplares similares

Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample
por: Kvam, Tor-Morten, et al.
Publicado: (2023)

Population Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics
por: Sexton, James D., et al.
Publicado: (2020)

Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics
por: de Vos, Cato M. H., et al.
Publicado: (2021)

Self-Medication for Chronic Pain Using Classic Psychedelics: A Qualitative Investigation to Inform Future Research
por: Bornemann, Julia, et al.
Publicado: (2021)

Psychedelics and workplace harm
por: Viña, Sean Matthew, et al.
Publicado: (2023)

Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?
por: Husain, Muhammad Ishrat, et al.
Publicado: (2023)

The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry
por: Kurtz, Joshua S, et al.
Publicado: (2022)

Psychedelics and Other Psychoplastogens for Treating Mental Illness
por: Vargas, Maxemiliano V., et al.
Publicado: (2021)

Commentary: Psychedelic Psychiatry's Brave New World
por: Nobile, Bénédicte, et al.
Publicado: (2020)

The Readiness of Psychiatrists to Implement Psychedelic-Assisted Psychotherapy
por: Page, Lisa A., et al.
Publicado: (2021)

Psychedelic Fauna for Psychonaut Hunters: A Mini-Review
por: Orsolini, Laura, et al.
Publicado: (2018)

Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics
por: Langlitz, Nicolas, et al.
Publicado: (2021)

How Psychedelic-Assisted Treatment Works in the Bayesian Brain
por: Villiger, Daniel
Publicado: (2022)

Ketamine for Bipolar Depression: Biochemical, Psychotherapeutic, and Psychedelic Approaches
por: Bennett, Raquel, et al.
Publicado: (2022)

The economics of psychedelic-assisted therapies: A research agenda
por: Marseille, Elliot, et al.
Publicado: (2022)

Psychedelic therapy in the treatment of addiction: the past, present and future
por: Zafar, Rayyan, et al.
Publicado: (2023)

Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique
por: Mosurinjohn, Sharday, et al.
Publicado: (2023)

Medical student attitudes and perceptions of psychedelic-assisted therapies
por: Li, Irene, et al.
Publicado: (2023)

Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder
por: Phan, Angela N., et al.
Publicado: (2023)

Co-design of Guidance for Patient and Public Involvement in Psychedelic Research
por: Close, James B., et al.
Publicado: (2021)

Bridging the Gap? Altered Thalamocortical Connectivity in Psychotic and Psychedelic States
por: Avram, Mihai, et al.
Publicado: (2021)

Behavioral Psychedelics: Integrating Mind and Behavior to Improve Health and Resilience
por: Neuhaus, Edmund C., et al.
Publicado: (2022)

Physical Disability and Psychedelic Therapies: An Agenda for Inclusive Research and Practice
por: Mintz, Kevin T., et al.
Publicado: (2022)

Knowing and being known: Psychedelic–assisted psychotherapy and the sense of authenticity
por: Fischman, Lawrence G.
Publicado: (2022)

Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review
por: Ko, Kwonmok, et al.
Publicado: (2022)

Classic Psychedelics and Human–Animal Relations
por: Pöllänen, Elin, et al.
Publicado: (2022)

Immunological evaluation of herbal extracts commonly used for treatment of mental diseases during pregnancy
por: Winker, Moritz, et al.
Publicado: (2023)

New Frontiers or a Bursting Bubble? Psychedelic Therapy Beyond the Dichotomy
por: Noorani, Tehseen, et al.
Publicado: (2021)

Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?
por: Kočárová, Rita, et al.
Publicado: (2021)

The Need for Psychedelic-Assisted Therapy in the Black Community and the Burdens of Its Provision
por: Smith, Darron T., et al.
Publicado: (2022)

Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes
por: Matzopoulos, Richard, et al.
Publicado: (2022)

From Underground to Mainstream: Establishing a Medical Lexicon for Psychedelic Therapy
por: Beswerchij, Andrew, et al.
Publicado: (2022)

Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy
por: Eleftheriou, Maria Eleni, et al.
Publicado: (2021)

Corrigendum: Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes
por: Matzopoulos, Richard, et al.
Publicado: (2022)

The association between naturalistic use of psychedelics and co-occurring substance use disorders
por: Rabinowitz, Jonina, et al.
Publicado: (2023)

Editorial: Appropriateness and safety of using cannabinoid and psychedelic medicines as treatments for psychiatric disorders
por: Blest-Hopley, Grace, et al.
Publicado: (2023)

A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development
por: Whitfield, Henry J.
Publicado: (2021)

The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics
por: Evens, Ricarda, et al.
Publicado: (2023)

Post-Psychedelic Reductions in Experiential Avoidance Are Associated With Decreases in Depression Severity and Suicidal Ideation
por: Zeifman, Richard J., et al.
Publicado: (2020)

Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers
por: Hutten, Nadia R. P. W., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e7abbdpv60uh731cnnf84luars